Harvard Bioscience Investor Relations Material
Latest events
Q3 2024
Harvard Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Harvard Bioscience Inc
Access all reports
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. It operates in two segments, Lab Products Group and Specialty Life Science Group. The Specialty Life Science Group segment manufactures and sells specialized life science research products to pharmaceutical companies and academic institutions. This segment offers large protein electrophysiological instrumentation, including voltage or current-clamp amplifiers; multi-photon excitation instruments used in optical imaging; scientific cameras and software; advanced microscopy; cell charting systems that detect morphological changes in cells; mass spectrometers; respirometers and other physiological measurement equipment; syringe pumps; microinjectors for small animals; oxygenators for tissue engineering applications used for cell culture work on a laboratory benchtop.
Key slides for Harvard Bioscience Inc
Q2 2024
Harvard Bioscience Inc
Q2 2024
Harvard Bioscience Inc
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
HBIO
Country
🇺🇸 United States